Abstract:Background Growing evidence indicates that dynamic changes in the gut microbiome can affect intelligence; however, whether the relationships are causal is unknown. Methods We conducted a bidirectional two-sample Mendelian randomization (MR) analysis using the summary statistics from the largest GWAS meta-analysis of gut microbiota composition (n = 18,340) and intelligence (n = 269,867). Inverse-variance weighted method was used to conduct the MR analyses complemented by a range of sensitivity analyses to validate the robustness of the results. We further applied a two-step MR analysis to evaluate whether the effect of identified taxa on intelligence was mediated by regulating the brain volume. Results MR evidence suggested a risk effect of the genus Oxalobacter on intelligence (β = –0.032; 95% confidence interval, –0.049 to –0.015; P = 1.88 ×10-4) and a protective effect of the genus Fusicatenibacter on intelligence (β = 0.051; 95% confidence interval, 0.023 to 0.079; P = 3.03× 10-4). In the other direction, we did not find causal evidence of intelligence on gut microbiome composition. The mediation analysis showed that the effect of genus Fusicatenibacter on intelligence was partly mediated by regulating the brain volume, with a mediated proportion of 26.7% (95% confidence interval, 4.9% to 48.5%). Conclusions Our findings may help reshape our understanding of the microbiota-gut-brain axis and development of novel intervention approaches for preventing cognitive impairment. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study is supported by the National Natural Science Foundation of China (82101601, 32170616), the Natural Science Basic Research Program of Shaanxi Province (2021JC-02), China Postdoctoral Science Foundation (2023T160517, 2021M702612, 2020M683454, 2021T140546), and the special guidance funds for the construction of world-class universities (disciplines) and characteristic development in central universities. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study used ONLY openly available human data that were originally located at: ; [https://ctg.cncr.nl/software/summary_statistics/][1] I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present work are contained in the manuscript [1]: https://ctg.cncr.nl/software/summary_statistics/s

S-57-5: GUT MICROBIOME DIVERSITY AND BRAIN VOLUME AMONG GENERAL JAPANESE MEN

Alteration of the Gut Microbiome in First-Episode Drug-Naïve and Chronic Medicated Schizophrenia Correlate with Regional Brain Volumes.

A causal relationship between gut microbiota and subcortical brain structures contributes to the microbiota–gut–brain axis: a Mendelian randomization study

Cerebral small vessel disease burden is associated with decreased abundance of gut Barnesiella intestinihominis bacterium in the Framingham Heart Study

The gut microbiome is associated with brain structure and function in schizophrenia

The association between alpha diversity of gut microbiota, neuroimaging markers and cognitive function in cerebral small vessel disease

Association of the Gut Microbiota With Cognitive Function in Midlife

Bowel Movement Frequency, the Gut Microbiome, and Cognitive Function in Women and Men

Mendelian Randomization Analyses Identify Causal Associations of Human Gut Microbiome Composition on Intelligence

Basic lifestyle habits and volume change in total gray matter among community dwelling middle-aged and older Japanese adults

Multimodal neuroimaging fusion biomarkers mediate the association between gut microbiota and cognition

Assessing the Joint Effects of Brain Aging and Gut Microbiota on the Risks of Psychiatric Disorders

Association Between Bowel-Movement Pattern and Cognitive Function: Prospective Cohort Study and a Metagenomic Analysis of the Gut Microbiome

Poor cognition is associated with increased abundance of Alistipes and decreased abundance of Clostridium genera in the gut

Brain Network Topology and Structural–Functional Connectivity Coupling Mediate the Association Between Gut Microbiota and Cognition

Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease

Metagenomic association analysis of cognitive impairment in community-dwelling older adults

The gut microbiota and coronary artery calcification in Japanese men

Characterizing Gut Microbiota in Older Chinese Adults with Cognitive Impairment: A Cross-Sectional Study

Dissecting the Association between Gut Microbiota and Brain Structure Change Rate: A Two-Sample Bidirectional Mendelian Randomization Study

Associations between gut microbiota and Alzheimer’s disease, major depressive disorder, and schizophrenia